Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalMarket CapitalizationReturn on AssetsReturn on Capital EmployedReturn on Equity

Corvus Pharmaceuticals (CRVS) Equity Ratio: 2022-2025

Historic Equity Ratio for Corvus Pharmaceuticals (CRVS) over the last 4 years, with Sep 2025 value amounting to 0.89.

  • Corvus Pharmaceuticals' Equity Ratio rose 322.69% to 0.89 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.89, marking a year-over-year increase of 322.69%. This contributed to the annual value of 0.47 for FY2024, which is 44.34% down from last year.
  • As of Q3 2025, Corvus Pharmaceuticals' Equity Ratio stood at 0.89, which was down 0.55% from 0.90 recorded in Q2 2025.
  • In the past 5 years, Corvus Pharmaceuticals' Equity Ratio ranged from a high of 0.90 in Q2 2025 and a low of 0.21 during Q3 2024.
  • Its 3-year average for Equity Ratio is 0.76, with a median of 0.84 in 2023.
  • Per our database at Business Quant, Corvus Pharmaceuticals' Equity Ratio slumped by 75.26% in 2024 and then surged by 322.69% in 2025.
  • Quarterly analysis of 4 years shows Corvus Pharmaceuticals' Equity Ratio stood at 0.82 in 2022, then increased by 3.27% to 0.85 in 2023, then slumped by 44.34% to 0.47 in 2024, then spiked by 322.69% to 0.89 in 2025.
  • Its Equity Ratio stands at 0.89 for Q3 2025, versus 0.90 for Q2 2025 and 0.83 for Q1 2025.